A novel antibody drug reactivates the immune defense in patients with advanced-stage cancer by altering the function of the body’s phagocytes and facilitating extensive activation of the immune system. The treatment may benefit patients for whom current treatment options are ineffective.

Read the Story

Show Top Comments

Alright so tell me why I’ll never hear of this come to frutition